Biopharmaceutical excipients aid in facilitating drug production, bioavailability, and stability, and may influence the medication's appearance, taste, and patient adherence, which drives the growth of the market.
What are Biopharmaceutical Excipients?
Biopharmaceutical excipients are small active molecules that are involved in therapeutic formulations, including monoclonal antibodies, recombinant proteins, vaccines, and gene therapies. Biopharmaceutical excipients play a crucial role in the advancement of biologics, as they improve the bioavailability, solubility, and tonicity of APIs. Biopharmaceutical excipients increase product results, stabilize the product, and lower operational costs. These excipients are significantly applied to stabilize a therapeutic drug’s biopharmaceutical and physicochemical characteristics. Excipients play a significant role in the biopharmaceutical sector, ensuring the bioavailability, stability, and effectiveness of therapeutic drugs.
Global Market Growth
The global biopharmaceutical excipients market size was estimated at USD 4.85 billion in 2025 and is predicted to increase from USD 5.23 billion in 2026 to approximately USD 10.37 billion by 2035, expanding at a CAGR of 7.9% from 2026 to 2035.
Recent Advancements in Bifunctional Excipients:
Recent advancements in bifunctional excipients have evolved to focus on solving challenges with the drugs' inherent biopharmaceutical properties, like poor solubility, permeability, in vivo dissolution, and efficient specificity. These advanced excipients potentially impact drug solubility, absorption rates, dissolution rates, permeation rates, penetration ability, targeting ability, and pharmacokinetic profiles. Bifunctional excipients involve a broad range of materials like smart and bio-adhesive polymers, surfactants, pH-modifiers, polymeric micelles, cyclodextrins, amino acids, lipids, in situ forming polymers, and various materials. These excipients are substances that influence biological functions, significantly influencing drug performance parameters like absorption, solubility, bioavailability, permeability, biodistribution, and pharmacokinetic profiles.
Market Segmentation Overview
- By product type, the organic chemicals segment contributed the largest U.S. biopharmaceutical excipients market share of 68% in 2025, as they are significant components of any therapeutics, being crucial to the efficacy, stability, and safety of the end product. Major organic excipients, specifically natural polymers, are non-toxic, well-tolerated, and non-irritant to the body.
- By functionality, the stabilizers segment contributed the largest market share of 30%, as stabilizers are used to support the active pharmaceutical ingredient (API), preserving the intended characteristics of the product until it is consumed by the patient. Stabilizers support the maintenance of the physical and chemical properties of the product, like texture, pH, and appearance, to confirm product effectiveness and safety. Stabilizers for pharmaceutical tablets, such as trehalose, confer the advantages of high solubility and simplicity of lyophilization.
- By formulation, the parenteral formulations segment contributed the largest U.S. biopharmaceutical excipients market share of 30%, as parenteral formulations support in emergencies when a rapid onset of action is needed, or when the patients can’t ingulf be delivered orally or topically. Parenteral formulations must be sterile, which adds a layer of complexity and requires strict adherence to regulatory rules.
- By end user, the biopharmaceutical companies segment contributed the largest market share of 42%, as biopharmaceutical excipients protect the active ingredient from degradation via external factors such as oxygen, light, and humidity. This confirms that the medication preserves its effectiveness over time. Excipients modify the release rate of the active ingredient, enabling sustained or controlled release formulations, which is significant for chronic disease scenarios.
Top Companies in the U.S. Biopharmaceutical Excipients Market
The top four organizations that dominated the U.S. biopharmaceutical excipients market. Meanwhile, Dow Chemicals, dealer for massive-scale manufacturing and functional excipients. Evonik Industries AG, it provides novel delivery systems and dedicated polymers. Roquette Frères specializes in plant-driven excipients. Colorcon Inc. is dedicated to coatings and manufacturing, including the AnyCoat line.
Segments Covered in the Report
By Product Type
- Organic Chemical
- Carbohydrates
- Sugars (Sucrose, Trehalose)
- Sugar Alcohols (Mannitol, Sorbitol)
- Oleochemicals
- Petrochemicals
- Inorganic Chemicals
- Calcium Phosphates
- Metal Oxides
- Halites
By Functionality
- Stabilizers
- Cryoprotectants
- Lyoprotectants
- Solubilizers & Surfactants
- Preservatives
- Antimicrobial Preservatives
- Buffers
- Phosphate Buffers
- Citrate Buffers
- Bulking Agents
- Others
- Chelating Agents
- Tonicity Modifiers
By Formulation
- Oral Formulations
- Parenteral Formulations
- Topical Formulations
- Pulmonary Formulations
By End User
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Research Laboratories
